Navigation Links
China Biologic Products Completes Acquisition of 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
Date:4/17/2009

TAIAN CITY, China, April 17 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), announced that it has completed the third installment payment towards the acquisition of a 90% equity interest in Chongqing Dalin Biologic Technologies Co., Ltd. ("Dalin") for a total consideration of RMB 194,400,000 (approximately $28.5 million), in accordance with the terms of an equity transfer agreement with the Dalin shareholders, and is now entitled to all the rights and privileges of a 90% shareholder in Dalin and in Dalin's 54% majority-owned operating subsidiary, Qianfeng Biological Products Co., Ltd. ("Qianfeng"), one of the largest plasma-based biopharmaceutical companies in China, located in Guiyang, Guizhou Province.

This installment represents the Company's payment of an aggregate 90% of the total purchase price, and according to the equity transfer agreement, as amended, Logic Holding (Hong Kong) Limited ("Logic Holding"), the Company's wholly-owned subsidiary, is now entitled to all the rights and privileges of a 90% shareholder in Dalin, including the right to receive its pro rata share of 54% of the profits generated by Qianfeng, as of January 1, 2009, subject to a possible dilution to as low as 41.3%, if a dissenting Qianfeng shareholder prevails in a pre-existing suit to obtain additional equity interests in Qianfeng.

On March 26, 2009, Dalin received a certificate of approval from the municipal government in Chongqing for the establishment of a Taiwan, Hong Kong, Macao and Overseas Chinese invested enterprise in China, which allows Dalin to operate as a Sino-foreign joint venture; and on April 10, 2009, Dalin, as a Sino-foreign joint venture, received business licenses from the Chongqing City Administration for Industry and Commerce
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results
2. China Sky One Medical, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Results
3. NeoStem Completes $11 Million Private Placement Financing to Support Expansion Activities in China, Further Development of NeoStems VSEL Technology and Advancement of Medical Tourism Initiatives
4. China Sky One Medical, Inc. Provides Update on Filing Form 10-K
5. China Agri-Business Announces 2008 Operating Results
6. China Biologic Products Announces Strong 2008 Results
7. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
8. China Biologic Products Completes Acquisition of 35% Interest in Xian Huitian Blood Products Co., Ltd.
9. China Bio Energy Reports Fourth Quarter and Record 2008 Financial Results
10. aTyr Pharma to Present at ChinaBio(R) Investor Forum in Hong Kong
11. Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the Peoples Republic of China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)...  SME,s Advanced Manufacturing Media is proud to announce ... celebrating young men and women who have demonstrated leadership ... of Manufacturing Engineering magazine highlights ... accomplishments. Among the standouts: Christopher Tyler , 28, ... the topology of flapping wing vehicles; Kathryn Tillery-Merk ...
(Date:7/7/2015)... ... July 07, 2015 , ... Since its inception ... area. What began as a conference for European Statistical Programmers, has evolved in ... the biometrical area. Statistical Programmers, Data Managers and Biostatisticians all over the world, ...
(Date:7/6/2015)... Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... used in ophthalmology and other medical fields holds potential to reveal how blood ... treatments and reduce stroke-induced damage to the brain. , A new article published ...
(Date:7/6/2015)... , July 6, 2015  Emdeon Inc. ... a definitive agreement to acquire Altegra Health, ... platforms that combine data aggregation and analytics ... to achieve actionable insights and improved management ... Altegra Health,s risk adjustment and quality analytics ...
Breaking Biology Technology:SME's Advanced Manufacturing Media Recognizes "30 Under 30" Future Leaders of Manufacturing 2SME's Advanced Manufacturing Media Recognizes "30 Under 30" Future Leaders of Manufacturing 3SME's Advanced Manufacturing Media Recognizes "30 Under 30" Future Leaders of Manufacturing 4SME's Advanced Manufacturing Media Recognizes "30 Under 30" Future Leaders of Manufacturing 5PhUSE Delighted to Welcome Member Number 5.000 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 3Emdeon to Acquire Altegra Health 2Emdeon to Acquire Altegra Health 3Emdeon to Acquire Altegra Health 4
... INC. (Nasdaq: VION ) today announced that the ... 7.75% Convertible Senior Notes due,2012 (the "Notes"). The aggregate ... Company paid $2,260,416.67 in interest through the issuance of,shares ... in,2,539,200 shares of Common Stock, based on today,s closing ...
... Ltd. (NASDAQ: HCTL ), today announced unaudited results for ... Revenues for the first six months of 2007 were ... of 2006. The gross profit for the,first half of the ... in 2006. The net loss for such period was $(319) ...
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), ... Listings Qualifications Department informed the Company that the,market ... million for 10,consecutive days, which is the requirement ... to Marketplace Rule 4450(b)(1)(A). Nasdaq,also informed the Company ...
Cached Biology Technology:Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes 2Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes 3Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results 2Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results 3Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 2Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 3Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter 4
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
(Date:6/24/2015)... , June 24, 2015 Biometry ... with emerging biometric password solution one face in. ... one face in, entering the ... ground-breaking and affordable multifactor-authentication biometric answer to the ... technology, provided in partnership with KeyLemon, one face ...
(Date:6/23/2015)... N.C. , June 23, 2015   ... today announced the results of a recent study ... accuracy on the wrist during activity. In a ... technology was compared along with the Apple Watch ... accurately measuring heart rate during activity. The study ...
Breaking Biology News(10 mins):Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... preserve grapes could help prevent allergies and boost healthy compounds ... Industry, the magazine of the SCI. The same technique could ... without the added sulphites that can cause asthma and other ... in storage for months and are usually treated with sulphur ...
... Researchers at Columbia University’s Mailman School of Public Health ... cancer. Using DNA isolated from serum samples as ... tumor suppressor genes that have been associated with the ... to prospectively examine potential biomarkers for early detection of ...
... normally used to treat insomnia, temporarily improved brain function ... in which the person is alert but cannot speak ... and eat without assistance after receiving the drug for ... the March 2007 issue of Annals of Neurology ( ...
Cached Biology News:Grape expectations for healthier wine 2Mailman School of Public Health researchers report blood DNA can be early predictor of liver cancer 2Insomnia drug can improve brain function 2
streptavidin, Alexa Fluor® 750–allophycocyanin conjugate (Alexa Fluor® 750–allophycocyanin streptavidin) *1 mg/mL*...
AedestaTM Animal Organ/Tissue Perfusion Soln....
Reusble. Uses in conjunction with the Apoptotic Cell Isolation Kit....
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: